H.C. Wainwright & Co., LLC
1 SPAC IPO underwritten · 0 as left lead · 0 active
H.C. Wainwright & Co., LLC is a New York-based investment bank best known for its focus on healthcare and life sciences capital markets. The firm made a single foray into the SPAC market in 2020, participating in one blank-check IPO without serving as a left-lead bookrunner. The firm currently carries no active SPAC mandates and no closed de-SPAC transactions on record, reflecting a limited and selective engagement with the vehicle relative to more prolific SPAC underwriters of that era. Investors and analysts tracking Wainwright's SPAC activity can access the complete filing history, deal timelines, and sector breakdowns by signing up for full data on SpacDesk.
| SPAC | Sponsor | IPO Size | Role | Status | IPO Date | Target |
|---|---|---|---|---|---|---|
| EUCR Eucrates Biomedical Acquisition Corp. | — | $100.0M | Co-Mgr | Liquidated | 2020-10-26 | — |
Underwriter data extracted from S-1 and S-1/A prospectus cover sheets filed with the SEC. Role classification (left lead, co-manager) based on syndicate position order. Trust size reflects declared trust at IPO.